Phase 1 Primary Progressive Multiple Sclerosis Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

Primary Progressive Multiple Sclerosis

Tr1X, Inc.39 enrolled2 locationsNCT07477639

Recruiting

Phase 1

SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis

Relapsing Remitting Multiple SclerosisPrimary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis

Queen Mary University of London72 enrolled1 locationNCT03783416